Statins (HMG-CoA reductase inhibitors) have been reported to reduce the occurrence of urinary tract infections, as they reduce susceptibility to bacteria [11,12,13], which corresponds with our findings. The gene discussed is HMGCR; the disease is urinary tract infection.